A phase 2, randomized, placebo-controlled, dose-ranging study of the calcium-sensing receptor antagonist MK-5442 in the treatment of postmenopausal women with osteoporosis (Q33570177)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase 2, randomized, placebo-controlled, dose-ranging study of the calcium-sensing receptor antagonist MK-5442 in the treatment of postmenopausal women with osteoporosis |
scientific article |
Statements
1 reference
A phase 2, randomized, placebo-controlled, dose-ranging study of the calcium-sensing receptor antagonist MK-5442 in the treatment of postmenopausal women with osteoporosis (English)
1 reference
Johan Halse
1 reference
Susan Greenspan
1 reference
Felicia Cosman
1 reference
Graham Ellis
1 reference
Arthur Santora
1 reference
Albert Leung
1 reference
Norman Heyden
1 reference
Suvajit Samanta
1 reference
Steven Doleckyj
1 reference
Elizabeth Rosenberg
1 reference
Andrew E Denker
1 reference
28 August 2014
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference